US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

63.03

+0.63191.01%

Volume:419

Turnover:26.43K

Market Cap:272.29M

PE:20.62

High:63.03

Open:63.03

Low:63.03

Close:62.40

52wk High:64.10

52wk Low:39.10

Shares:4.32M

Float Shares:4.32M

Volume Ratio:0.71

T/O Rate:0.01%

Dividend:1.53

Dividend Rate:2.43%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2

BMO starts Exelixis at Market Perform into patent cliff

Roivant Sciences (ROIV) Receives a Buy from Jefferies

Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test

Simply Wall St.

Streamlined Business Environment Boost: Digital Re-Inspection Approval Lets Companies Handle Matters Remotely

Nancheng County Market Watch Intensifies Medical Supply Checks at Village Clinics

Pinggu Pioneers "Zero-Visit" Medical Device License Approval, Cutting Processing Time by 50%

Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million

BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG

Cullinan Climbs as Lung Cancer Drug Meets Late-Stage Trial Goal

Transformation Drive: How a 1 Billion Yuan Capacity Firm Used Shanghai's First Medical Device License to Unlock Nanxiang Life Valley's 'Rainforest' Incubation Path

Shuozhou City Market Regulation Bureau Conducts Cross-Inspection of Medical Device Safety

Medical Equipment Procurement Shows Sustained Monthly Recovery, Sector Valuations Poised for Rebound

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

Liquidia Q2 Revenue Jumps on Yutrepia Sales

Axsome Therapeutics (AXSM) Receives a Buy from Mizuho Securities

Ningyang County Market Regulation Bureau Launches Special Inspection on Optometry Instruments

New Batch of National Standards Released, Including Autonomous Driving Safety and AI Medical Device Quality

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Axsome's Auvelity Strength Expected to Drive H2 Revenue Growth, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PTH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":63.03,"timestamp":1787664750557,"preClose":62.3981,"halted":0,"volume":419,"delay":0,"changeRate":0.010126910915556751,"floatShares":4320000,"shares":4320000,"eps":3.057033,"marketStatus":"Trading","change":0.6319,"latestTime":"08-25 09:36:00 EDT","open":63.03,"high":63.03,"low":63.03,"amount":26430.731595,"amplitude":0,"askPrice":63.58,"askSize":500,"bidPrice":63.1,"bidSize":500,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.3981,"sharesOutstanding":2480000,"nav":62.98271,"aum":273974788.5,"dividendRate":0.024255,"bidAskSpread":0.002049,"postHourTrading":{"tag":"盘后","latestPrice":62.41,"preClose":62.3981,"latestTime":"19:30 EDT","volume":14,"amount":872.8867,"timestamp":1787614203296,"change":0.0119,"changeRate":0.000191,"amplitude":0},"volumeRatio":0.709635,"impliedVol":0.188,"impliedVolPercentile":0.9203},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.709635,"shares":4320000,"dividePrice":1.5288,"high":63.03,"amplitude":0,"preClose":62.3981,"low":63.03,"week52Low":39.1,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":63.03,"eps":3.057033,"divideRate":0.024255,"volume":419,"delay":0,"ttmEps":3.057033,"open":63.03,"prevYearClose":49.701,"prevWeekClose":62.9761,"prevMonthClose":58.0963,"prevQuarterClose":59.76,"fiveDayClose":60.7585,"twentyDayClose":57.983,"sixtyDayClose":51.9608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660970474","title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2660970474","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660970474?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:15","pubTimestamp":1787091347,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa disposes of 116 common shares worth $18,148.2Guardant Health director Tariq Musa sold 116 common shares on Aug. 17 at USD 156.45.The sale cut his directly held stak","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbdy8Tn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","GNMX","LU0889565916.HKD","BK4588","GH","HELX","GDOC","EKG","BK4196","GNOM","LFSC","LU0320765992.SGD","BK4551","BK4585","BK4535","LU0109394709.USD","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492411","title":"BMO starts Exelixis at Market Perform into patent cliff","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492411?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:30","pubTimestamp":1787085023,"startTime":"0","endTime":"0","summary":"BMO Capital initiated coverage of Exelixis (EXEL) with a Market Perform rating and $54 price target Exelixis is anchored by cabozantinib, a “durabl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU2272731600.USD","IHE","BK4585","FTXH","LU2272731782.SGD","LU2322448791.USD","PPH","LU2322448957.HKD","BBH","LU2272731865.HKD","SYNB","MEDI","RSPH","RXD","IYH","GSKH","LU1992135399.USD","APXH","FXH","MEDX","LU2473716301.USD","JDOC","FBT","XPH","BK4532","BME","BK4207","PJP","EXEL","PBPH","RXL","LU1992135472.HKD","IE00B5TLWC47.USD","AZNH","BMO","PTH","BK4588","FHLC","TRUH","BK4139","TMED","CURE","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660933564","title":"Roivant Sciences (ROIV) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2660933564","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660933564?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:05","pubTimestamp":1787061919,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Buy rating on Roivant Sciences today and set a price target of $42.00. In addition to Jefferies, Roivant Sciences al...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roivant-sciences-roiv-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roivant-sciences-roiv-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","BK4007","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495332","title":"Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495332","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495332?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:26","pubTimestamp":1787059570,"startTime":"0","endTime":"0","summary":"Why Guardant Health Stock Is Back on Investors’ Radar\nGuardant Health (GH) moved into focus after several Q2 2026 developments, including FDA approval of an updated Guardant360 liquid biopsy test and new American Cancer Society support for its Shield colorectal cancer screening.\nThese clinical and guideline milestones arrived alongside stronger than expected Q1 results related to test volume and coverage trends. This provided investors with fresh information on how the company’s product...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-back-in-focus-as-new-approvals-put-valuat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-back-in-focus-as-new-approvals-put-valuat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GDOC","LU0889565916.HKD","BK4585","GH","BK4535","BK4196","GNMX","HELX","LU0320765992.SGD","BK4551","GNOM","FFOX","BK4588","EKG","LFSC","LU0109394709.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182114698","title":"Streamlined Business Environment Boost: Digital Re-Inspection Approval Lets Companies Handle Matters Remotely","url":"https://stock-news.laohu8.com/highlight/detail?id=1182114698","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182114698?lang=en_us&edition=fundamental","pubTime":"2026-08-18 07:40","pubTimestamp":1787010033,"startTime":"0","endTime":"0","summary":"A medical device logistics firm in Cangzhou Economic Development Zone has become an early beneficiary of a new digital service that eliminates the need for physical visits during approval...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEIH","HART","PTH","BK1574","09996","GDOC","LNGR","RSPH","BK1583","MEDX","BK1100","AGNG","MDEV","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199985936","title":"Nancheng County Market Watch Intensifies Medical Supply Checks at Village Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=1199985936","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199985936?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:03","pubTimestamp":1786957404,"startTime":"0","endTime":"0","summary":"The Market Supervision Administration of Nancheng County, Jiangxi Province, has recently ramped up enforcement efforts, conducting dedicated inspections of pharmaceuticals and medical devices at...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","AGNG","BK1574","09996","GDOC","LGHT","MEDX","LNGR","HART","IEIH","MDEV","PTH","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137742397","title":"Pinggu Pioneers \"Zero-Visit\" Medical Device License Approval, Cutting Processing Time by 50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137742397","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137742397?lang=en_us&edition=fundamental","pubTime":"2026-08-14 13:10","pubTimestamp":1786684228,"startTime":"0","endTime":"0","summary":"A business representative in Daxingzhuang Town, Pinggu District, who recently obtained a medical device business license, remarked, \"In the past, getting a license meant repeatedly revising documents...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","MDEV","LGHT","159883","PTH","MEDX","BK1100","IEIH","AGNG","BK1574","HART","LNGR","RSPH","BK1583","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659719596","title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659719596","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659719596?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:21","pubTimestamp":1786663307,"startTime":"0","endTime":"0","summary":"Guardant Health Chief People Officer Terilyn Monroe disposes of common shares worth $7.61 millionGuardant Health Chief People Officer Terilyn J. Monroe cut her direct common stock stake to 22,979 shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1rsYJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4535","HELX","LU0889565916.HKD","GH","PTH","LFSC","GDOC","LU0320765992.SGD","BK4551","BK4588","GNMX","GNOM","BK4585","EKG","FFOX","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156635","title":"BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156635","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156635?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:03","pubTimestamp":1786618980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BTSG/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU2324357040.USD","PSCH","BK4196","BTSG","PTH","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659130742","title":"Cullinan Climbs as Lung Cancer Drug Meets Late-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2659130742","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659130742?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:39","pubTimestamp":1786613984,"startTime":"0","endTime":"0","summary":"BUZZ-Cullinan climbs as lung cancer drug meets late-stage trial goal** Shares of Cullinan TherapeuticsCGEM.Orise 6% to $20.77 premarket** Cullinan says its experimental cancer drug, zipalertinib, when","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4N44A0QA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","CGEM","IE0009354923.USD","IDNA","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","CANC","IE00B4R5TH58.HKD","BBH","LU0320765992.SGD","RVMD","PTH","BK4139","IE00BFTCPJ56.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151434530","title":"Transformation Drive: How a 1 Billion Yuan Capacity Firm Used Shanghai's First Medical Device License to Unlock Nanxiang Life Valley's 'Rainforest' Incubation Path","url":"https://stock-news.laohu8.com/highlight/detail?id=1151434530","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151434530?lang=en_us&edition=fundamental","pubTime":"2026-08-13 15:40","pubTimestamp":1786606856,"startTime":"0","endTime":"0","summary":"In the first half of this year, Jiading District's strategic emerging industries accounted for 41.4% of total industrial output value above a designated size, with the three leading sectors achieving...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","IEIH","RSPH","HART","09996","AGNG","GDOC","MDEV","LGHT","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163427165","title":"Shuozhou City Market Regulation Bureau Conducts Cross-Inspection of Medical Device Safety","url":"https://stock-news.laohu8.com/highlight/detail?id=1163427165","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163427165?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:50","pubTimestamp":1786600255,"startTime":"0","endTime":"0","summary":"Shuozhou City Market Regulation Bureau has recently intensified oversight of medical device quality and safety across the entire supply chain, from distribution to clinical use. The initiative aims...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","GDOC","PTH","AGNG","HART","09996","BK1574","LNGR","IEIH","BK1583","BK1100","MDEV","RSPH","159883","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128373791","title":"Medical Equipment Procurement Shows Sustained Monthly Recovery, Sector Valuations Poised for Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1128373791","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128373791?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:18","pubTimestamp":1786576706,"startTime":"0","endTime":"0","summary":"GTHT has released a research report noting that the ongoing implementation of equipment renewal policies is expected to drive long-term increases in medical equipment procurement levels. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CZA","LGHT","BK0276","REVS","BK0201","BK1100","HART","MEDX","MDEV","AGNG","159883","LNGR","601211","BK1147","BK0188","RSPH","02611","BK0184","NIFE","BK0183","BK1564","IEIH","BK0028","PTH","09996","BK0012","BK1574","BK1583","GDOC","LCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086429","title":"Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086429","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086429?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:30","pubTimestamp":1786537800,"startTime":"0","endTime":"0","summary":"Contrasting Science with Revolution Medicines and ErascaMELBOURNE, Australia, Aug.  12, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutica","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343641/0/en/propanc-biopharma-highlights-differentiated-proenzyme-therapy-prp-as-a-potential-therapy-of-choice-against-ras-driven-cancers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861215975.USD","LU1861219969.SGD","CANC","IE00BZ199S13.USD","PTH","ON","BBH","LU1861214812.USD","RVMD","LU1854104046.USD","LU2298322129.HKD","LU1861220033.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2357305700.SGD","IE0002141913.USD","ERAS","CHH","LU0320765992.SGD","LU1548497426.USD","LU0124384867.USD","LU1720051017.SGD","LU1983260115.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4512","BK4139","LU1720051108.HKD","IE00BFMHRM44.USD","IE00BJT1NW94.SGD","IDNA","BK4142","BK4539","LU1978683503.SGD","IE0009355771.USD","BK4585","IE00BD6J9T35.USD","BK4141","LU0109394709.USD","BK4588","LU0724618433.USD","LU0348723411.USD","BK4605","PDX","LU1854103824.USD","LU2360107325.USD","IE00B2B36J28.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658979562","title":"Liquidia Q2 Revenue Jumps on Yutrepia Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2658979562","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658979562?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:39","pubTimestamp":1786531153,"startTime":"0","endTime":"0","summary":"Liquidia Q2 revenue jumps on YUTREPIA salesOverviewU.S. biopharma firm's Q2 sales revenue rose sharply on YUTREPIA salesEPS for Q2 met analyst expectationsCompany posted fourth consecutive quarter of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490C3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4505","AXSM","BK4585","LU2324357040.USD","BK4588","LQDA","BK4139","BK4007","BBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658621979","title":"Axsome Therapeutics (AXSM) Receives a Buy from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2658621979","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658621979?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:36","pubTimestamp":1786530986,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Axsome Therapeutics today and set a price target of $316.00. According to Ti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/axsome-therapeutics-axsm-receives-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/axsome-therapeutics-axsm-receives-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSIB","BK4207","LU2324357040.USD","BK4585","MFG","PTH","BK4505","BK4007","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126627296","title":"Ningyang County Market Regulation Bureau Launches Special Inspection on Optometry Instruments","url":"https://stock-news.laohu8.com/highlight/detail?id=1126627296","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126627296?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:32","pubTimestamp":1786523522,"startTime":"0","endTime":"0","summary":"On August 11, enforcement officers from the Ningyang County Market Regulation Bureau in Shandong Province conducted a special medical device inspection at eyewear retail stores in the area. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","LNGR","BK1574","BK1583","AGNG","MEDX","IEIH","GDOC","BK1100","PTH","LGHT","09996","HART","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119178651","title":"New Batch of National Standards Released, Including Autonomous Driving Safety and AI Medical Device Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=1119178651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119178651?lang=en_us&edition=fundamental","pubTime":"2026-08-12 15:21","pubTimestamp":1786519304,"startTime":"0","endTime":"0","summary":"A significant set of 338 national standards has been approved by the State Administration for Market Regulation's Standardization Administration.This release includes 15 mandatory and 323 recommended...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4593","NJUL","FDIF","AGNG","GK","PBOT","QQQX","159883","09996","FAI","161631","AIQU","NAPR","MVPS","CARZ","PSQ","QID","MDEV","NBDS","QQA","FWD","03086","QDEC","CPNQ","02834","AQGX","NEWZ","CWC","RSPH","LGHT","QLD","07568","XT","VUSE","IEIH","IQM","TQQQ","AIFD","03455","TQQY","CHAT","MOTO","QMAR","TARK","SQQQ","AIBU","MFIG","09086","HAIL","03034","IDRV","LCLG","DRIV","AGIX","DQJN","07266","LNGR","MEDX","09834","QQQM","07261","WPAI","NJAN","TECY","QQQ","07522","OGIG","BK1583","PTH","ARTY","KOMP","GPIQ","NOCT","BK1100","QTOC","QSWN","ROBT","GDOC","HART","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949165","title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949165","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949165?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:23","pubTimestamp":1786487005,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Commercial Officer Chris Freeman disposes of $ 10.75 million in common sharesGuardant Health Chief Commercial Officer Chris Freeman exercised stock options for 63,605 shares on A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4khYKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","GNMX","BK4535","GDOC","LU0889565916.HKD","EKG","GH","PTH","FFOX","GNOM","LU0109394709.USD","BK4196","HELX","LU0320765992.SGD","BK4588","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911089","title":"Axsome's Auvelity Strength Expected to Drive H2 Revenue Growth, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911089","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911089?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:51","pubTimestamp":1786463486,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics'  Q2 results showed continued strength from Auvelity, its treatment for major depressive disorder, with the drug's new indication expected to drive revenue growth in H2, RBC Capital Markets said Monday in a report.Auvelity generated $180 million in revenue in the quarter, topping Wall Street's $176 million estimate, \"which may help to drive some incremental upside as investors lift their outlook for the drug,\" the report said.Continued expansion of Auvelity's use in major depressive disorder, including potential benefits from long-term care, should support total revenue of $804 million in 2026, the report said.Auvelity sales may reach $4.3 billion by 2035, with peak sales potentially reaching $5 billion to $6 billion, and the longer-term opportunity is still not fully reflected in Axsome's share price, the report said.RBC lowered its price target on Axsome stock to $297 from $304 and maintained its outperform rating.Price: 220.55, Change: -0.34, Percent Change: -0.1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTH","LU2324357040.USD","AXSM","BK4585","BK4007","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}